A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...

Clinical data presented at ASCO 2025 showed an objective response rate (ORR) of 63% among all patients, with a median progression-free survival (PFS) of 7.7 months. Responses were seen across ...

Leuprorelin acetate, a medicine approved in the U.S. for prostate cancer, may slow the progression of SMA type SBMA, ...

I was one in eight. One in eight men will be diagnosed with prostate cancer in their lifetime. Nah, I was one in six. One in ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early ...

The U.S. Food and Drug Administration has granted regular approval to treatment with Rubraca (rucaparib) for the treatment of ...

Cliff Richard, 85, said in an interview with “Good Morning Britain” that he was diagnosed with prostate cancer in 2024 after ...

LONDON -- British pop star Cliff Richard said Monday he has been given the all-clear after treatment for prostate cancer. The ...

Dec. 15, 2025 — For decades, when tests suggested that a man might have prostate cancer, the next step was usually a biopsy. The procedure, where a doctor uses a thin needle to collect prostate ...

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

Prostate cancer tests in the UK will only be offered to men with a specific cancer gene variant in a controversial decision that will put pressure on the government to overrule the advice. Targeted ...

More than 63,000 men are diagnosed with prostate cancer annually in the UK, with over 12,000 dying from the disease each year, according to Prostate Cancer UK. The prostate is a gland located next to ...